Notably, as expected, the COL1A1+/COL1A2+/IGFBP2+ fibroblast-like cells especially MSC-like-c2 present strong interactions with malignant tumor cells (MTC), which confirms our observation from in-house data. The gene discussed is IGFBP2; the disease is cancer.